| (Values in U.S. Thousands) | Jun, 2022 | Mar, 2022 | Dec, 2021 | Sep, 2021 | Jun, 2021 |
| Sales | 71,550 | 55,160 | 56,100 | 52,050 | 47,560 |
| Sales Growth | +29.71% | -1.68% | +7.78% | +9.44% | +21.82% |
| Net Income | -82,470 | -81,420 | -87,580 | -70,990 | -69,590 |
| Net Income Growth | -1.29% | +7.03% | -23.37% | -2.01% | +7.13% |
Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops treatments for underserved patient communities.
Fiscal Year End Date: 12/31